Ticagrelor 90 MG Oral Tablet — RxCUI 1116635
RxNorm drug concept · Semantic clinical drug
RxCUI 1116635
Semantic clinical drug · SCD
● Current RxNorm concept 48 FDA products
93 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1116635
Official nameTicagrelor 90 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped48
Package NDCs mapped93
Reported Medicaid activity (SDUD)190,826 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ticagrelor: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Because of how quickly your body clears ticagrelor — its half-life is only about 7 hours — twice-daily dosing is needed to keep enough of the drug in your system to protect you aro...
- Why do I have to take ticagrelor twice a day — can I just take it once?
- Shortness of breath is actually one of the more common side effects of ticagrelor — roughly 1 in 7 people experience it. The good news is it's usually mild to moderate, it doesn't...
- I've been feeling short of breath since I started ticagrelor. Should I be worried?
🕸️ Concept Web — How Ticagrelor 90 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ticagrelor 90 MG Oral Tablet
RxCUI 1116635 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ticagrelor
1116632IN
-
Ticagrelor
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Brilinta
1116636BN
-
Brilinta
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ticagrelor Oral Tablet
1116634SCDF -
Ticagrelor Oral Product
1157089SCDG -
Ticagrelor Pill
1157090SCDG -
Ticagrelor Oral Tablet [Brilinta]
1116638SBDF -
Brilinta Oral Product
1176340SBDG -
Brilinta Pill
1176341SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Ticagrelor Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ticagrelor 90 MG
1116633SCDC -
Ticagrelor 90 MG Oral Tablet [Brilinta]
1116639SBD -
Ticagrelor 90 MG [Brilinta]
1116637SBDC
-
Ticagrelor 90 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ticagrelor 90 MG
SCDC · 1116633 -
Ticagrelor Oral Tablet
SCDF · 1116634 -
Ticagrelor Oral Product
SCDG · 1157089 -
Ticagrelor Pill
SCDG · 1157090
Brand-Name Concepts
-
Ticagrelor 90 MG Oral Tablet [Brilinta]
SBD · 1116639 -
Ticagrelor 90 MG [Brilinta]
SBDC · 1116637 -
Ticagrelor Oral Tablet [Brilinta]
SBDF · 1116638 -
Brilinta Oral Product
SBDG · 1176340 -
Brilinta Pill
SBDG · 1176341 -
Brilinta
BN · 1116636
📦 FDA Products & Package NDCs
48 products · 93 package NDCs
93 package NDCs map to RxCUI 1116635 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00186-0776-60 | 60 TABLET in 1 BOTTLE (0186-0776-60) | BRILINTA | AstraZeneca Pharmaceuticals LP | 2015-09-04 |
| 00186-0777-39 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0186-0777-39) / 10 TAB... | BRILINTA | AstraZeneca Pharmaceuticals LP | 2011-08-05 |
| 00186-0777-60 | 60 TABLET in 1 BOTTLE (0186-0777-60) | BRILINTA | AstraZeneca Pharmaceuticals LP | 2011-08-05 |
| 00378-2214-91 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2214-91) | Ticagrelor | Mylan Pharmaceuticals Inc. | 2025-09-25 |
| 00378-2215-91 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2215-91) | Ticagrelor | Mylan Pharmaceuticals Inc. | 2025-09-25 |
| 00480-2688-06 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-2688-06) | Ticagrelor | Teva Pharmaceuticals, Inc. | 2025-05-01 |
| 00480-2695-06 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-2695-06) | Ticagrelor | Teva Pharmaceuticals, Inc. | 2025-05-01 |
| 11788-0157-60 | 60 TABLET in 1 BOTTLE (11788-157-60) | Ticagrelor | AiPing Pharmaceutical, Inc | 2026-06-10 |
| 11788-0158-01 | 100 TABLET in 1 BOTTLE (11788-158-01) | Ticagrelor | AiPing Pharmaceutical, Inc | 2026-06-10 |
| 11788-0158-60 | 60 TABLET in 1 BOTTLE (11788-158-60) | Ticagrelor | AiPing Pharmaceutical, Inc | 2026-06-10 |
| 33342-0431-09 | 60 TABLET, FILM COATED in 1 BOTTLE (33342-431-09) | Ticagrelor | Macleods Pharmaceuticals Limited | 2025-10-28 |
| 33342-0431-12 | 10 BLISTER PACK in 1 CARTON (33342-431-12) / 10 TABLET, FIL... | Ticagrelor | Macleods Pharmaceuticals Limited | 2025-10-28 |
| 33342-0432-09 | 60 TABLET, FILM COATED in 1 BOTTLE (33342-432-09) | Ticagrelor | Macleods Pharmaceuticals Limited | 2025-10-28 |
| 33342-0432-12 | 10 BLISTER PACK in 1 CARTON (33342-432-12) / 10 TABLET, FIL... | Ticagrelor | Macleods Pharmaceuticals Limited | 2025-10-28 |
| 42658-0115-03 | 60 TABLET, FILM COATED in 1 BOTTLE (42658-115-03) | Ticagrelor | Hisun Pharmaceuticals USA, Inc. | 2025-05-01 |
| 43547-0657-06 | 60 TABLET, FILM COATED in 1 BOTTLE (43547-657-06) | TICAGRELOR | Solco Healthcare U.S., LLC | 2025-04-01 |
| 43547-0657-18 | 180 TABLET, FILM COATED in 1 BOTTLE (43547-657-18) | TICAGRELOR | Solco Healthcare U.S., LLC | 2025-04-01 |
| 43547-0657-50 | 500 TABLET, FILM COATED in 1 BOTTLE (43547-657-50) | TICAGRELOR | Solco Healthcare U.S., LLC | 2025-04-01 |
| 43598-0480-18 | 180 TABLET in 1 BOTTLE (43598-480-18) | Ticagrelor | Dr. Reddys Laboratories Inc | 2025-04-30 |
| 43598-0480-60 | 60 TABLET in 1 BOTTLE (43598-480-60) | Ticagrelor | Dr. Reddys Laboratories Inc | 2025-04-30 |
| 43598-0480-78 | 10 BLISTER PACK in 1 CARTON (43598-480-78) / 10 TABLET in 1... | Ticagrelor | Dr. Reddys Laboratories Inc | 2025-04-30 |
| 43598-0480-79 | 1 BLISTER PACK in 1 CARTON (43598-480-79) / 10 TABLET in 1... | Ticagrelor | Dr. Reddys Laboratories Inc | 2025-04-30 |
| 43598-0629-18 | 180 TABLET in 1 BOTTLE (43598-629-18) | Ticagrelor | Dr. Reddys Laboratories Inc | 2025-10-28 |
| 43598-0629-60 | 60 TABLET in 1 BOTTLE (43598-629-60) | Ticagrelor | Dr. Reddys Laboratories Inc | 2025-10-28 |
| 46708-0241-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-241-30) | Ticagrelor | Alembic Pharmaceuticals Limited | 2025-05-01 |
| 46708-0241-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-241-31) | Ticagrelor | Alembic Pharmaceuticals Limited | 2025-05-01 |
| 46708-0241-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-241-60) | Ticagrelor | Alembic Pharmaceuticals Limited | 2025-05-01 |
| 46708-0241-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-241-91) | Ticagrelor | Alembic Pharmaceuticals Limited | 2025-05-01 |
| 46708-0500-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-500-60) | Ticagrelor | Alembic Pharmaceuticals Limited | 2025-10-28 |
| 46708-0500-71 | 500 TABLET, FILM COATED in 1 BOTTLE (46708-500-71) | Ticagrelor | Alembic Pharmaceuticals Limited | 2025-10-28 |
| 50228-0521-10 | 1000 TABLET in 1 BOTTLE (50228-521-10) | ticagrelor | ScieGen Pharmaceuticals INC | 2025-10-09 |
| 50228-0521-30 | 30 TABLET in 1 BOTTLE (50228-521-30) | ticagrelor | ScieGen Pharmaceuticals INC | 2025-10-09 |
| 50228-0521-60 | 60 TABLET in 1 BOTTLE (50228-521-60) | ticagrelor | ScieGen Pharmaceuticals INC | 2025-10-09 |
| 50228-0522-10 | 1000 TABLET in 1 BOTTLE (50228-522-10) | ticagrelor | ScieGen Pharmaceuticals INC | 2025-10-09 |
| 50228-0522-30 | 30 TABLET in 1 BOTTLE (50228-522-30) | ticagrelor | ScieGen Pharmaceuticals INC | 2025-10-09 |
| 50228-0522-60 | 60 TABLET in 1 BOTTLE (50228-522-60) | ticagrelor | ScieGen Pharmaceuticals INC | 2025-10-09 |
| 50268-0826-01 | 100 BLISTER PACK in 1 BOX (50268-826-01) / 1 TABLET in 1 BL... | TICAGRELOR | AvPAK | 2025-10-29 |
| 51407-0861-60 | 60 TABLET in 1 BOTTLE (51407-861-60) | Ticagrelor | Golden State Medical Supply, Inc. | 2025-05-05 |
| 55154-9618-00 | 10 BLISTER PACK in 1 BAG (55154-9618-0) / 1 TABLET in 1 BLI... | BRILINTA | Cardinal Health 107, LLC | 2011-08-05 |
| 55154-9618-08 | 1440 TABLET in 1 BOTTLE, PLASTIC (55154-9618-8) | BRILINTA | Cardinal Health 107, LLC | 2011-08-05 |
| 55488-0543-01 | 60 TABLET in 1 BOTTLE (55488-0543-1) | Ticagrelor | Changzhou Pharmaceutical Factory | 2025-10-28 |
| 55488-0543-02 | 500 TABLET in 1 BOTTLE (55488-0543-2) | Ticagrelor | Changzhou Pharmaceutical Factory | 2025-10-28 |
| 55488-0544-01 | 60 TABLET in 1 BOTTLE (55488-0544-1) | Ticagrelor | Changzhou Pharmaceutical Factory | 2025-10-28 |
| 55488-0544-02 | 500 TABLET in 1 BOTTLE (55488-0544-2) | Ticagrelor | Changzhou Pharmaceutical Factory | 2025-10-28 |
| 60505-4452-06 | 60 TABLET in 1 BOTTLE (60505-4452-6) | Ticagrelor | Apotex Corp. | 2025-05-01 |
| 60505-4453-06 | 60 TABLET in 1 BOTTLE (60505-4453-6) | Ticagrelor | Apotex Corp. | 2025-10-31 |
| 60687-0928-57 | 60 BLISTER PACK in 1 CARTON (60687-928-57) / 1 TABLET in 1... | Ticagrelor | American Health Packaging | 2025-12-01 |
| 60687-0935-21 | 30 BLISTER PACK in 1 CARTON (60687-935-21) / 1 TABLET in 1... | Ticagrelor | American Health Packaging | 2026-01-04 |
| 62332-0241-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-241-30) | Ticagrelor | Alembic Pharmaceuticals Inc. | 2025-05-01 |
| 62332-0241-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-241-31) | Ticagrelor | Alembic Pharmaceuticals Inc. | 2025-05-01 |
Observed labelers:
Novadoz Pharmaceuticals LLC (8) ·
Alembic Pharmaceuticals Inc. (6) ·
Alembic Pharmaceuticals Limited (6) ·
Cipla USA Inc. (6) ·
Dr. Reddys Laboratories Inc (6) ·
Exelan Pharmaceuticals, Inc (6)
· +22 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.